367514-88-3

Lurasidone hydrochloride (Lurasidone HCl) is a thiazole derivative and atypical antipsychotic agent that functions as a dopamine D2 receptor antagonist; serotonin 5-HT2 receptor antagonist, serotonin 5-HT7 receptor antagonist, an antagonist of the adrenergic α2A and α2C receptors, as well as a partial serotonin 5-HT1A receptor agonist. It is used in the treatment of schizophrenia and bipolar disorder.

Lurasidone-[D4] Hydrochloride (Standard) is a reference standard of Lurasidone-[D4] Hydrochloride intended for quantitative analysis, quality control, and related biochemical research applications.

Lurasidone (Standard) is a reference standard for research and analysis in studies involving Lurasidone. Lurasidone (SM-13496) is an antagonist of both dopamine D2 and 5-HT7(IC50=1.68 and 0.495 nM, respectively).It also a partial agonist of 5-HT1A receptor(IC50 : 6.75 nM).

Lurasidone (SM-13496) is an antagonist of dopamine D2 and 5-HT7 receptors (IC50 = 1.68 and 0.495 nM, respectively) and a partial agonist of the 5-HT1A receptor (IC50 = 6.75 nM).

lurasidone-D8 is a deuterated compound of lurasidone (TMSM-3492).

Lurasidone-[D8] Hydrochloride (Standard) is a reference standard of Lurasidone-[D8] Hydrochloride intended for quantitative analysis, quality control, and related biochemical research applications.

Lurasidone-D8 hydrochloride is a deuterated compound of Lurasidone hydrochloride. Lurasidone hydrochloride has a CAS number of 367514-88-3. Lurasidone hydrochloride (T1735) is a thiazole derivative and atypical antipsychotic agent that functions as a dopamine D2 receptor antagonist; serotonin 5-HT2 receptor antagonist, serotonin 5-HT7 receptor antagonist, an antagonist of the adrenergic α2A and α2C receptors, as well as a partial serotonin 5-HT1A receptor agonist. It is used in the treatment of schizophrenia and bipolar disorder.

Lurasidone-D8 hydrochloride is an inhibitor of Dopamine D2, 5-HT2A, 5-HT7, 5-HT1A and noradrenaline α2C, and is the deuterium labeled Lurasidone Hydrochloride (T1735).